Phase III CBD Clinical Trial Recruitment Update

Melbourne, Australia, 18 December 2025: Avecho Biotechnology Limited (ASX: AVE) (“Avecho” or the “Company”) is pleased to provide a progress update on recruitment for its pivotal Phase III clinical trial (the “Trial”) investigating the use of its oral CBD TPM®-enhanced capsule (“the Product”) for the treatment of insomnia. Avecho continues to make steady progress toward completion of patient recru